BlueCrest Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-24,570	Closed	-$400K	–	1030
2018 Q3	$400K	Buy	+24,570	New	+$400K	0.01%	861
2017 Q2	–	Sell	-17,728	Closed	-$81K	–	941
2017 Q1	$81K	Buy	+17,728	New	+$81K	﹤0.01%	665